Performant Healthcare Inc financial data

Symbol
PHLT on Nasdaq
Location
900 South Pine Island Road, Suite 150, Plantation, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 265 % -11.9%
Debt-to-equity 34.6 % +21.5%
Return On Equity -7.8 % +16.1%
Return On Assets -0.84 % +86.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 79M shares +2.34%
Common Stock, Shares, Outstanding 78.3M shares +1.81%
Entity Public Float 128M USD +6.78%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 78.6M shares +2.09%
Weighted Average Number of Shares Outstanding, Diluted 80.7M shares +4.88%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 137M USD +15.2%
Operating Income (Loss) -48K USD +99.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -868K USD +87%
Income Tax Expense (Benefit) 17K USD +2150%
Net Income (Loss) Attributable to Parent -885K USD +86%
Earnings Per Share, Basic 0 USD/shares +87.5%
Earnings Per Share, Diluted 0 USD/shares +87.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.08M USD -12.9%
Accounts Receivable, after Allowance for Credit Loss, Current 17.7M USD +26.1%
Assets, Current 47.5M USD +24.5%
Property, Plant and Equipment, Net 13.9M USD -5.6%
Operating Lease, Right-of-Use Asset 1.06M USD +13.7%
Goodwill 47.4M USD 0%
Other Assets, Noncurrent 863K USD +11.2%
Assets 111M USD +8.32%
Accounts Payable, Current 1.07M USD +20.5%
Employee-related Liabilities, Current 11.9M USD +42.4%
Accrued Liabilities, Current 2.1M USD +23.5%
Contract with Customer, Liability, Current 359K USD -57.7%
Liabilities, Current 18M USD +25.1%
Operating Lease, Liability, Noncurrent 546K USD +16.9%
Other Liabilities, Noncurrent 95K USD -85.7%
Liabilities 28.7M USD +8.08%
Retained Earnings (Accumulated Deficit) -73.2M USD -1.22%
Stockholders' Equity Attributable to Parent 82.2M USD +8.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 78.1M USD +0.63%
Liabilities and Equity 111M USD +8.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.9M USD +2300%
Net Cash Provided by (Used in) Financing Activities -765K USD -5364%
Net Cash Provided by (Used in) Investing Activities -1.45M USD +60.3%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 79M shares +2.34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 689K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.08M USD -12.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 227K USD +78.7%
Deferred Tax Assets, Valuation Allowance 15.8M USD +36.4%
Deferred Tax Assets, Gross 16.6M USD +35.4%
Operating Lease, Liability 1.08B USD +13.7%
Depreciation 1.5M USD -21.1%
Payments to Acquire Property, Plant, and Equipment 1.45M USD -60.3%
Lessee, Operating Lease, Liability, to be Paid 1.18B USD +11.9%
Property, Plant and Equipment, Gross 64.5M USD -21.6%
Operating Lease, Liability, Current 536K USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 227M USD +27.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 525M USD +43.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +10000%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 93M USD -5.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 112M USD -0.89%
Deferred Tax Assets, Operating Loss Carryforwards 9.15M USD +27.6%
Unrecognized Tax Benefits 7K USD -97.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 106K USD +76.7%
Operating Lease, Payments 200K USD +100%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.65M USD +24.6%
Deferred Tax Assets, Net of Valuation Allowance 805K USD +18.4%
Share-based Payment Arrangement, Expense 7.4M USD +64.4%
Interest Expense 1.75M USD +37.9%